Caris Research
Equity Research By Nicholas Aberle
Click here to sign up for a Caris Research Account
3/02/2010
(MRVL) MRVL (Caris Price Target Change)-MRVL: Reiterating Positive Thesis Ahead of FQ4 Earnings, Increasing EPS Estimates and Bumping Price Target to $24.00
No introduction text is currently available for this report.
2/24/2010
(VLTR) VLTR (Caris Update)-Long-Term Thesis Gathering Momentum, Reiterating 2*/Above Average and $25.00 Price Target
No introduction text is currently available for this report.
2/18/2010
(NVDA) NVDA (Caris Update)-Strong FQ4 Results Constrained by Tight Supply, Maintaining 3*/Average Rating and Price Target of $15.00
No introduction text is currently available for this report.
2/16/2010
(NVDA) NVDA: FQ4 Earnings Preview, Increasing Estimates and Bumping Price Target to $15.00, Maintain 3*/Average Rating
No introduction text is currently available for this report.
2/03/2010
(NETL) NETL (Caris Price Target Change)-Finding the Knee in the Curve, Increasing Estimates, Reiterating 1*/Buy Rating and Raising Price Target to $56.00
No introduction text is currently available for this report.
1/29/2010
(EXAR) EXAR - Beat & Raise, Gross Margin Expansion Drives EPS Leverage, Maintaining 3*/AVG Rating and $8.00 Price Target
No introduction text is currently available for this report.
1/29/2010
(MCRL) MCRL - Strong FQ3 Results with Decent Guidance, Maintaining 4*/Below Average Rating & Price Target of $7.00
No introduction text is currently available for this report.
1/27/2010
(IDTI) IDTI: Modest FQ3 Upside Followed by Seasonal Guidance, Maintaining 3*/Avg and Price Target of $6.00
No introduction text is currently available for this report.
1/26/2010
(VLTR) VLTR - Blow-Out Quarter and the Best Is Yet to Come, Reiterating 2*/Above Average and Raising PT to $25.00
No introduction text is currently available for this report.
1/26/2010
(ZRAN) ZRAN - FQ4 Results In-Line but Gross Margin Prospects Are Encouraging, Maintaining 3*/Average Rating
No introduction text is currently available for this report.
Depending on the investment objectives and financial information specific to your situation, the investments discussed or recommended on this website may or may not be suitable for you. It is your responsibility to consider any investment decision carefully. The information contained on this website should not be construed as advice designed to meet the particular needs of any investor. Past performance is not necessarily indicative of future performance, and does not guarantee future results. The price and/or value of any security noted directly or indirectly on this website may fluctuate adversely to your interests, and/or those of other investors. Caris & Company accepts no liability whatsoever for loss or damage of any sort arising out of use of all or part of any information on this website.